Results
Filtros
SUS and Health Insurance Plans
01/01/2024Learn How to Access Cannabis Products Through the Unified Health System and Understand the Obligations of Health Insurance Providers
Sergipe discusses expanding medical cannabis policy in SUS
Meeting of the State Health Council discussed new protocols and free access to cannabis-based products in the public network
InCor and universities lead list of projects selected by Medicinal Cannabis Call
With an investment of R$ 1.25 million, the initiative from São Paulo boosts studies in health, agriculture, veterinary, and social inclusion
The political cost of ignoring cannabis at COP30
In Belém, Brazil celebrates the Amazon, but leaves aside a plant capable of driving sustainability, innovation, and social justice
Third sector leads number of proposals submitted in the Alesp Cannabis Front Edict
Public universities and Municipalities close the top three; $1.25 million will be allocated to medicinal cannabis and industrial hemp projects
Third sector leads number of proposals submitted in the Alesp Cannabis Front Edict
Public universities and Municipalities close the top three; R$ 1.25 million will be allocated to medicinal cannabis and industrial hemp projects
Medicinal cannabis will be produced in São Paulo with public structure, says governor
Governor confirms that Furp will be responsible for the production of plant-based medications, amid announcement of R$ 379 million for municipal health
Reatech 2025 opens space for debate on medical cannabis and inclusion
The "Cannabis in Focus" event takes place in November and aims to discuss the therapeutic use of medical cannabis in Brazil
Eduardo Suplicy demands regulation of medicinal cannabis in an open letter to President Lula
Eduardo Suplicy demands regulation of medicinal cannabis in an open letter to President Lula
In record time: City Council approves distribution of medicinal cannabis and sanction is on the way
Pereira Barreto creates Medicinal Cannabis Policy focusing on atypical families and patients with degenerative diseases
Cannabis Congress Kicks Off with a Bang: Market, Animal Health, and the Future of the Plant in Focus
With over 100 speakers, the Brazilian Cannabis Congress begins with major debates and promises three historic days at the largest event in Latin America.
São Paulo regulates the use of medicinal cannabis in the municipal SUS
Patients with ASD, fibromyalgia, and chronic pain will be able to access cannabidiol-based medications through the public network
“Good politics are made in defense of people,” says mayor of Bolsonaro's party about pioneering medicinal cannabis project in the interior of SP
In partnership with the Flor da Vida Association, mayor of conservative party opens medicinal cannabis clinic and advocates for free access to patients
Ribeirão Pires inaugurates Brazil's first public medical cannabis clinic
Pioneering service from the City Hall and Flor da Vida Association will provide free care, through SUS, to patients with ASD and other specific conditions
Santos approves law for the supply of medicinal cannabis in SUS
12/21/2023Working Group and Regulation to be formed in 30 days to facilitate access to products based on the plant
Cannabis in the Community: Debate Goes to the Paraisópolis Favela/SP
06/02/2023Event aims to disseminate quality information about health, therapeutic use, entrepreneurship, and historical reparation in peripheral territories
After four months in prison, medical cannabis patient receives judicial recognition for personal use
The student accused of drug trafficking for growing cannabis is acquitted of the charges and is now facing trial while free
The Myth of "superweed" influencing media and justice
Analysis shows how sensationalist expression shapes social and legal perceptions in Brazil
The Myth of "superweed" influencing media and Justice
Analysis shows how sensationalist expression shapes social and legal perceptions in Brazil
36% of Parkinson's patients use natural products to relieve symptoms, cannabis among the most used
Study conducted in the Netherlands interviewed 367 people; most of them do not discuss the use of natural products with their doctors in treating Parkinson's